American Society of Hirudotherapy

Bdellins A/B

Dual-family proteinase inhibitors with exceptional neurotrophic potency

Last Updated: May 27, 2026Reviewed by: Andrei Dokukin, MD
Biochemistry & mechanismNot a clinical efficacy claim

Last updated: June 18, 2026

Mechanism Disclaimer

Biological mechanism discussion does not imply therapeutic efficacy outside FDA-cleared contexts.

Bdellins comprise two structurally distinct groups of proteinase inhibitors isolated from Hirudo medicinalis salivary gland secretion. Despite sharing protease targets (trypsin, plasmin, acrosin), Group A and Group B belong to entirely different structural families — a remarkable example of convergent functional evolution within a single organism.

Classification and Structure

PropertyGroup A (Bdellastatin)Group B (Bdellin B3)HMW Bdellin B
Molecular weight6,300 Da (59 aa)5,000 Da20,000 Da
Structural familyAntistasin familyNon-classical Kazal-typeKazal-type (extended)
Disulfide bonds5 S-S bonds3 S-S bondsMultiple
Homology29% to antistasin55% to LDTIExtended C-terminal domain
Reactive siteP1 Lys34Canonical Kazal loopKazal loop + membrane binding

Bdellin B3 spans only 37 amino acids between its first and last cysteine residues, making it among the shortest Kazal-type inhibitors known. The high-molecular-weight bdellin B (20 kDa) features an extended C-terminal domain that enables membrane binding — unique among leech Kazal-type inhibitors.

Inhibitory Specificity

Trypsin

Ki = 0.1 nM. Sub-nanomolar inhibition of trypsin-like serine proteases. Biological function: modulates trypsin activity in the leech intestinal canal, where Aeromonas symbionts secrete trypsin-like enzymes for blood digestion.

Plasmin

Ki = 0.1 nM. Potent plasmin inhibition prevents premature fibrinolysis of the blood meal within the leech crop. In the host context, plasmin inhibition modulates tissue remodeling and inflammatory proteolysis.

Acrosin

Acrosin is a trypsin-like serine protease from sperm acrosome. Bdellin inhibition of acrosin reflects the broad-spectrum anti-trypsin activity rather than a specific reproductive biological function of the leech.

Neurotrophic Activity

Neurotrophic Activity Among the Bdellins

Bdellin B

EAI increase at 0.05 ng/mL — among tested SGS components in chick embryo dorsal root ganglia (Chapter 7).

Bdellastatin

Also reported to stimulate neurite outgrowth in explant culture at low concentrations (Chalisova et al., 2003), alongside its trypsin/plasmin-inhibitory activity.

EAI = Explant Area Index, a standardized measure of neurite outgrowth from dorsal root ganglia explants.

Recombinant Production and Applications

Recombinant Bdellastatin

Moser et al. (1998) achieved heterologous expression of bdellastatin in Saccharomyces cerevisiae (yeast). The yeast expression system was necessary to ensure proper formation of the five disulfide bonds critical for antistasin family fold — bacterial expression systems failed to produce active protein.

Anti-Inflammatory Potential

By inhibiting trypsin-like proteases at sub-nanomolar concentrations, bdellins contribute to the suppression of tissue degradation during inflammatory responses. Their dual anti-inflammatory and neurotrophic activities suggest multifunctional therapeutic potential in neuroinflammatory conditions.

Related Resources

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.